vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and PROCORE TECHNOLOGIES, INC. (PCOR). Click either name above to swap in a different company.

Genius Sports Ltd is the larger business by last-quarter revenue ($510.9M vs $349.1M, roughly 1.5× PROCORE TECHNOLOGIES, INC.). PROCORE TECHNOLOGIES, INC. runs the higher net margin — -10.8% vs -12.3%, a 1.6% gap on every dollar of revenue. PROCORE TECHNOLOGIES, INC. produced more free cash flow last quarter ($109.2M vs $69.6M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 13.8%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

Procore Technologies is an American construction management software as a service company founded in 2002, with headquarters in Carpinteria, California. Procore hosts a platform to connect those involved in the construction industry on a global platform. The software allows for the creation of simplified workflows and displays a consolidated view of construction products that includes the tracking of tasks, management of project workflows, and scheduling.

GENI vs PCOR — Head-to-Head

Bigger by revenue
GENI
GENI
1.5× larger
GENI
$510.9M
$349.1M
PCOR
Higher net margin
PCOR
PCOR
1.6% more per $
PCOR
-10.8%
-12.3%
GENI
More free cash flow
PCOR
PCOR
$39.7M more FCF
PCOR
$109.2M
$69.6M
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
13.8%
PCOR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GENI
GENI
PCOR
PCOR
Revenue
$510.9M
$349.1M
Net Profit
$-63.0M
$-37.6M
Gross Margin
25.2%
80.1%
Operating Margin
-11.5%
-12.3%
Net Margin
-12.3%
-10.8%
Revenue YoY
15.6%
Net Profit YoY
39.6%
EPS (diluted)
$-0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
PCOR
PCOR
Q4 25
$510.9M
$349.1M
Q3 25
$335.4M
$338.9M
Q2 25
$215.2M
$323.9M
Q1 25
$119.7M
$310.6M
Q4 24
$413.0M
$302.0M
Q3 24
$285.8M
$295.9M
Q2 24
$184.1M
$284.3M
Q1 24
$97.2M
$269.4M
Net Profit
GENI
GENI
PCOR
PCOR
Q4 25
$-63.0M
$-37.6M
Q3 25
$-9.1M
Q2 25
$-47.3M
$-21.1M
Q1 25
$-25.5M
$-33.0M
Q4 24
$-85.5M
$-62.3M
Q3 24
$-47.1M
$-26.4M
Q2 24
$-35.5M
$-6.3M
Q1 24
$-25.2M
$-11.0M
Gross Margin
GENI
GENI
PCOR
PCOR
Q4 25
25.2%
80.1%
Q3 25
24.2%
79.7%
Q2 25
19.1%
79.1%
Q1 25
10.7%
79.1%
Q4 24
16.7%
81.2%
Q3 24
20.5%
81.4%
Q2 24
18.6%
83.1%
Q1 24
9.8%
83.0%
Operating Margin
GENI
GENI
PCOR
PCOR
Q4 25
-11.5%
-12.3%
Q3 25
-15.3%
-4.4%
Q2 25
-21.0%
-9.3%
Q1 25
-20.3%
-11.7%
Q4 24
-18.0%
-21.9%
Q3 24
-13.9%
-12.3%
Q2 24
-16.8%
-5.2%
Q1 24
-23.7%
-7.0%
Net Margin
GENI
GENI
PCOR
PCOR
Q4 25
-12.3%
-10.8%
Q3 25
-2.7%
Q2 25
-22.0%
-6.5%
Q1 25
-21.3%
-10.6%
Q4 24
-20.7%
-20.6%
Q3 24
-16.5%
-8.9%
Q2 24
-19.3%
-2.2%
Q1 24
-25.9%
-4.1%
EPS (diluted)
GENI
GENI
PCOR
PCOR
Q4 25
$-0.25
Q3 25
$-0.06
Q2 25
$-0.14
Q1 25
$-0.22
Q4 24
$-0.42
Q3 24
$-0.18
Q2 24
$-0.04
Q1 24
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
PCOR
PCOR
Cash + ST InvestmentsLiquidity on hand
$280.6M
$768.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$724.5M
$1.3B
Total Assets
$1.1B
$2.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
PCOR
PCOR
Q4 25
$280.6M
$768.5M
Q3 25
$110.2M
$684.0M
Q2 25
$110.2M
$620.9M
Q1 25
$110.2M
$566.7M
Q4 24
$100.3M
$775.4M
Q3 24
$100.3M
$756.9M
Q2 24
$100.3M
$735.4M
Q1 24
$100.3M
$744.6M
Stockholders' Equity
GENI
GENI
PCOR
PCOR
Q4 25
$724.5M
$1.3B
Q3 25
$572.4M
$1.2B
Q2 25
$572.4M
$1.2B
Q1 25
$572.4M
$1.2B
Q4 24
$573.0M
$1.3B
Q3 24
$573.0M
$1.3B
Q2 24
$573.0M
$1.3B
Q1 24
$573.0M
$1.2B
Total Assets
GENI
GENI
PCOR
PCOR
Q4 25
$1.1B
$2.2B
Q3 25
$792.3M
$2.1B
Q2 25
$792.3M
$2.0B
Q1 25
$792.3M
$1.9B
Q4 24
$775.7M
$2.1B
Q3 24
$775.7M
$2.0B
Q2 24
$775.7M
$2.0B
Q1 24
$775.7M
$1.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
PCOR
PCOR
Operating Cash FlowLast quarter
$81.9M
$114.9M
Free Cash FlowOCF − Capex
$69.6M
$109.2M
FCF MarginFCF / Revenue
13.6%
31.3%
Capex IntensityCapex / Revenue
2.4%
1.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$33.5M
$282.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
PCOR
PCOR
Q4 25
$81.9M
$114.9M
Q3 25
$-4.8M
$88.5M
Q2 25
$-1.2M
$30.8M
Q1 25
$-14.6M
$66.0M
Q4 24
$14.9M
$29.1M
Q3 24
$-9.2M
$39.3M
Q2 24
$58.7M
Q1 24
$69.1M
Free Cash Flow
GENI
GENI
PCOR
PCOR
Q4 25
$69.6M
$109.2M
Q3 25
$-14.2M
$83.1M
Q2 25
$-5.8M
$27.9M
Q1 25
$-16.0M
$62.0M
Q4 24
$11.3M
$17.4M
Q3 24
$-11.6M
$35.7M
Q2 24
$56.8M
Q1 24
$67.1M
FCF Margin
GENI
GENI
PCOR
PCOR
Q4 25
13.6%
31.3%
Q3 25
-4.2%
24.5%
Q2 25
-2.7%
8.6%
Q1 25
-13.4%
20.0%
Q4 24
2.7%
5.8%
Q3 24
-4.1%
12.1%
Q2 24
20.0%
Q1 24
24.9%
Capex Intensity
GENI
GENI
PCOR
PCOR
Q4 25
2.4%
1.6%
Q3 25
2.8%
1.6%
Q2 25
2.1%
0.9%
Q1 25
1.2%
1.3%
Q4 24
0.9%
3.9%
Q3 24
0.9%
1.2%
Q2 24
0.7%
Q1 24
0.8%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GENI
GENI

Segment breakdown not available.

PCOR
PCOR

US$298.3M85%
Non Us$50.9M15%

Related Comparisons